What are the responsibilities and job description for the Open-Rank, Tenure-Track Assistant/Associate/Full Professor, Molecular Aging Research position at CHEManager International?
Heritage College of Osteopathic Medicine
Department of Biomedical Sciences
The Institute for Molecular Medicine and Aging (IMMA)
Ohio University, Athens, Ohio
The Institute for Molecular Medicine and Aging (IMMA) and the Department of Biomedical Sciences at Ohio University’s Heritage College of Osteopathic Medicine (HCOM) invite applications for a tenure-track faculty position (Assistant, Associate, or Full Professor) in the field of molecular aging research. This position is part of a strategic effort to expand Ohio University’s growing research enterprise in healthy aging.
Position Description
We seek a research-intensive tenure track faculty whose research program addresses fundamental or translational questions in molecular aging. Areas of interest include, but are not limited to:
Cellular and molecular mechanisms of aging Metabolic and inflammatory regulation of age-related diseases (such as osteoarthritis, osteoporosis, dementia, cancer, et al.) System-specific aging (e.g., bone, endocrine, immune, nervous system, cardiovascular system) Systems biology, omics, or regenerative approaches to aging Compound discovery to treat aging co-morbidities Applicants with federally-funded research programs and strong records of publication are especially encouraged to apply. Candidates at the mid-career or senior level who can contribute to and help shape the scientific vision of IMMA will receive priority consideration; however, exceptional early-career investigators are also encouraged to apply. Leadership opportunities within the institute are available to qualified candidates.
The Successful Candidate Will Be Expected To
Establish and maintain a vigorous extramurally funded research program Participate in the growth and leadership of IMMA Drive innovation and discovery that advance the institute’s mission and foster translational impact Engage in the protection and development of intellectual property arising from research discoveries Collaborate with existing IMMA, OMNI (Ohio Musculoskeletal and Neurological Institute), and DI (Diabetes Institute) investigators Appointment and Resources
9-month, tenure-track appointment in the Department of Biomedical Sciences, Heritage College of Osteopathic Medicine Final workload distribution is negotiable but will approximate 80% Research, 10% Teaching, and 10% Service. Competitive start-up package and dedicated laboratory space in the new biomedical research building (opening 2026; temporary facilities available until move-in) Pay Rate & Benefits
Ph.D., M.D., D.O., or equivalent degree in a relevant biomedical field Research focus related to aging biology, metabolism, age-associated diseases, and/or drug discovery Preferred Qualifications
Demonstrated Record Of And Potential For Sustained Extramural Funding Strong Record Of Peer-reviewed Publications In Molecular Aging Or Geroscience Evidence Of Leadership, Mentorship, And Program Development Applicants Should Be Prepared To Submit The Following
Curriculum vitae Cover letter describing research interests and career goals Statement of research accomplishments and future plans (2 pages) Contact information for three references Applications will be reviewed immediately and continue until the position is filled. For full consideration, please apply by December 11, 2025.
About The Institute For Molecular Medicine And Aging (IMMA)
The newly reframed Institute for Molecular Medicine and Aging (IMMA) was formerly known as the Edison Biotechnology Institute (EBI). Founded in 1984, EBI was one of the earliest state-supported biotechnology research centers in Ohio and quickly became a leader in the region’s biomedical innovation ecosystem. EBI’s faculty and collaborators have made seminal contributions to understanding the molecular and hormonal regulation of growth, metabolism, cancer, and aging, and its discoveries have led to patented technologies and therapeutic developments with global impact. For example, EBI scientists discovered a growth hormone receptor antagonist that led to the development of Pegvisomant (Somavert), a life-changing therapy for patients with acromegaly now used worldwide. Extension of this work established the GH/IGF-1 signaling pathway as a key regulator of lifespan and metabolic health. These landmark discoveries continue to shape modern aging and endocrine research, providing the scientific foundation for ongoing innovation within the Institute for Molecular Medicine and Aging (IMMA).
IMMA advances mechanistic and translational research on the molecular basis of aging and its impact on healthspan and disease susceptibility. IMMA brings together scientists studying metabolism, inflammation, fibrosis, senescence, regeneration, neurobiology with a focus on dementia, cancer, and osteoarthritis to uncover how molecular and cellular pathways drive aging processes across organ systems. Another significant portion of IMMA is the discovery of new compounds that, hopefully, will evolve into FDA approved therapeutics for morbidities associated with the above-mentioned study areas.
Learn more at: https://www.ohio.edu/medicine/institute-molecular-medicine-aging
About BMS
The selected candidate will join a diverse group of faculty in the Department of Biomedical Sciences, https://www.ohio.edu/medicine/about/departments/biomedical.
Department of Biomedical Sciences
The Institute for Molecular Medicine and Aging (IMMA)
Ohio University, Athens, Ohio
The Institute for Molecular Medicine and Aging (IMMA) and the Department of Biomedical Sciences at Ohio University’s Heritage College of Osteopathic Medicine (HCOM) invite applications for a tenure-track faculty position (Assistant, Associate, or Full Professor) in the field of molecular aging research. This position is part of a strategic effort to expand Ohio University’s growing research enterprise in healthy aging.
Position Description
We seek a research-intensive tenure track faculty whose research program addresses fundamental or translational questions in molecular aging. Areas of interest include, but are not limited to:
Cellular and molecular mechanisms of aging Metabolic and inflammatory regulation of age-related diseases (such as osteoarthritis, osteoporosis, dementia, cancer, et al.) System-specific aging (e.g., bone, endocrine, immune, nervous system, cardiovascular system) Systems biology, omics, or regenerative approaches to aging Compound discovery to treat aging co-morbidities Applicants with federally-funded research programs and strong records of publication are especially encouraged to apply. Candidates at the mid-career or senior level who can contribute to and help shape the scientific vision of IMMA will receive priority consideration; however, exceptional early-career investigators are also encouraged to apply. Leadership opportunities within the institute are available to qualified candidates.
The Successful Candidate Will Be Expected To
Establish and maintain a vigorous extramurally funded research program Participate in the growth and leadership of IMMA Drive innovation and discovery that advance the institute’s mission and foster translational impact Engage in the protection and development of intellectual property arising from research discoveries Collaborate with existing IMMA, OMNI (Ohio Musculoskeletal and Neurological Institute), and DI (Diabetes Institute) investigators Appointment and Resources
9-month, tenure-track appointment in the Department of Biomedical Sciences, Heritage College of Osteopathic Medicine Final workload distribution is negotiable but will approximate 80% Research, 10% Teaching, and 10% Service. Competitive start-up package and dedicated laboratory space in the new biomedical research building (opening 2026; temporary facilities available until move-in) Pay Rate & Benefits
- Salary will be commensurate with education and experience, while also considering internal equity. Retirement Match: The university offers an excellent retirement plan with an institutional match of up to 14%. Benefits: medical, vision, dental, basic and supplemental life, paid holidays, sick leave, retirement, a 12-week parental leave program, adoption reimbursement, flextime and flexplace policies, counseling and mental health care, access to professional development programs and more. Tuition Waiver and Support: A tuition waiver of up to 100% for self and dependents.
Ph.D., M.D., D.O., or equivalent degree in a relevant biomedical field Research focus related to aging biology, metabolism, age-associated diseases, and/or drug discovery Preferred Qualifications
Demonstrated Record Of And Potential For Sustained Extramural Funding Strong Record Of Peer-reviewed Publications In Molecular Aging Or Geroscience Evidence Of Leadership, Mentorship, And Program Development Applicants Should Be Prepared To Submit The Following
Curriculum vitae Cover letter describing research interests and career goals Statement of research accomplishments and future plans (2 pages) Contact information for three references Applications will be reviewed immediately and continue until the position is filled. For full consideration, please apply by December 11, 2025.
About The Institute For Molecular Medicine And Aging (IMMA)
The newly reframed Institute for Molecular Medicine and Aging (IMMA) was formerly known as the Edison Biotechnology Institute (EBI). Founded in 1984, EBI was one of the earliest state-supported biotechnology research centers in Ohio and quickly became a leader in the region’s biomedical innovation ecosystem. EBI’s faculty and collaborators have made seminal contributions to understanding the molecular and hormonal regulation of growth, metabolism, cancer, and aging, and its discoveries have led to patented technologies and therapeutic developments with global impact. For example, EBI scientists discovered a growth hormone receptor antagonist that led to the development of Pegvisomant (Somavert), a life-changing therapy for patients with acromegaly now used worldwide. Extension of this work established the GH/IGF-1 signaling pathway as a key regulator of lifespan and metabolic health. These landmark discoveries continue to shape modern aging and endocrine research, providing the scientific foundation for ongoing innovation within the Institute for Molecular Medicine and Aging (IMMA).
IMMA advances mechanistic and translational research on the molecular basis of aging and its impact on healthspan and disease susceptibility. IMMA brings together scientists studying metabolism, inflammation, fibrosis, senescence, regeneration, neurobiology with a focus on dementia, cancer, and osteoarthritis to uncover how molecular and cellular pathways drive aging processes across organ systems. Another significant portion of IMMA is the discovery of new compounds that, hopefully, will evolve into FDA approved therapeutics for morbidities associated with the above-mentioned study areas.
Learn more at: https://www.ohio.edu/medicine/institute-molecular-medicine-aging
About BMS
The selected candidate will join a diverse group of faculty in the Department of Biomedical Sciences, https://www.ohio.edu/medicine/about/departments/biomedical.
